Pharmaceutical & Life Sciences News

Latest Stories

Europe Hits China With Medical Devices Probe Before Xi Visit

The European Union launched an investigation into China’s procurement of medical devices, the latest in a spate of actions that are raising tension ahead of President Xi Jinping’s first visit to the bloc in five years.

By Alberto Nardelli

Nursing Homes, HHS on Collision Path Over Staffing Mandate

The Biden administration’s push to improve nursing home care through better staffing—and the industry’s insistence that it needs more workers and funding to make it happen—could set the stage for intervention by Congress or the courts.

Emergency Abortion Clash at Supreme Court Tests Strictest Bans

The US Supreme Court will consider just how far states can go in prohibiting abortion Wednesday as it weighs whether emergency room doctors nationwide can perform the procedure when a pregnant woman’s health is at serious risk.

Wegovy Access Expands to Millions in US on Medicare, Study Finds

Medicare’s recent decision to cover Novo Nordisk A/S’s blockbuster obesity shot Wegovy for heart disease will possibly subsidize the drug for some 3.6 million people, according to a new study from Kaiser Family Foundation.

Universal Injunctions’ Outsize Effects May Spur Justices to Act

Columnist David Lat explains the controversy behind universal injunctions and their impact on public policy and judicial power.

Sanofi Said to Ask Banks to Pitch for $20 Billion Spinoff

French drugmaker <-bsp-bb-link state="{"bbHref":"bbg://securities/SAN%20FP%20Equity/CACS","_id":"0000018f-0f4c-d583-afbf-cfdcfb9e0000","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">Sanofi has asked banks to pitch for roles on the separation of its consumer-health business, according to people familiar with the matter, one of the biggest deals likely to happen in Europe this year.

Pharma Giants Fight for Covid Vaccine Profits in UK Trial

Moderna Inc.’s patents for Covid-19 vaccine must be declared invalid, Pfizer Inc argued at the start of a UK patent dispute that could help decide how billions of dollars in vaccine profits are shared between the pharmaceutical firms.

Novartis Says Malaria Drug for Babies Shows Positive Results

Novartis AG released encouraging data from a study of a medicine designed for babies with malaria, a potential leap in the global fight against the mosquito-borne disease.

California Hospitals Sue Anthem, Alleging Delays Cost Billions

Blue Cross of California‘s failure to coordinate necessary longer-term care after hospital stays contributes to backlogs and at least $3.25 billion in preventable costs annually, alleged a suit filed Tuesday in California state court.

Ex-Stanford President’s AI Drug Startup Pulls in $1 Billion

<-bsp-person state="{"_id":"0000018f-0d51-d583-afbf-cfdd10150000","_type":"00000160-6f41-dae1-adf0-6ff519590003"}">Marc Tessier-Lavigne, the former president of <-bsp-bb-link state="{"bbHref":"bbg://securities/8178942Z%20US%20Equity","_id":"0000018f-0d51-d583-afbf-cfdd10150001","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">Stanford University who resigned last year after questions arose about his scientific research, has a new job as chief executive officer of a drug development startup.